LFMD
LifeMD, Inc. Common Stock
SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE
LifeMD (LFMD) Stock: Buy, Sell, or Hold?
$2.20
+0.54 (+32.63%)
â˛
5d:
-7.38%
30d:
-10.77%
90d:
-33.89%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 12, 2026
0d
Protect LFMD Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
46/100
Position
FAIR
30-Day Fair Range
$2.02 â $2.56
Position: FAIR
Forward P/E & Valuation
5.8x
CHEAP
vs 12.8x historical avg
Wall Street Target
$8.13
+270.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.60 / $2.49
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: LFMD is fairly priced but lacks strong directional signals. At -23.2% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When LFMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$6.82
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.23
48.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LFMD is currently trading at $2.19, which is considered fair relative to its 30-day fair value range of $2.02 to $2.56. From a valuation perspective, the stock is trading at a discount (Forward PE: 5.8) compared to its historical average (12.8). Remarkably, the market is currently pricing in an annual earnings decline of 23.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LFMD is in a strong downtrend. Immediate support is located at $1.60, while resistance sits at $2.49. The stock is showing strong short-term momentum, up 32.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.12 (+270.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LFMD is in a strong downtrend. Immediate support is located at $1.60, while resistance sits at $2.49. The stock is showing strong short-term momentum, up 32.6% recently.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $8.12 (+270.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.02 -
$2.56
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
Trading Range & Key Levels
30-Day Trading Range
$2.02 -
$2.56
Current vs Trading Range
FAIR
Support Level
$1.60
Resistance Level
$2.49
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding LFMD? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+32.6%)
- BULLISH: Trading 270.2% below Wall St target ($8.12)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
5.78
Wall Street Target
$8.13
(+270.2%)
Revenue Growth (YoY)
-25.8%
Profit Margin
-0.4%
Valuation Discount vs History
-23.2% cheaper
PE vs Historical
5.8 vs 12.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-23.2%
(market-implied from PE analysis)
1-Year Target
$1.98
(-10%)
2-Year Target
$1.78
(-19%)
3-Year Target
$1.60
(-27%)
3-Yr Target (if PE normalizes)
(PE: 6â13)
$3.55
(+62%)
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 5.8 to 12.8
Stabilization Target:
$4.86
(+121.6%)
PE Expansion Potential:
+121.6%
Share LFMD Analysis
Share this live LFMD analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (LFMD)
Bearish
4 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 13, 2026
Daily AI digest
AI Retail Discussion Summary:
LifeMD reported Q3 revenue of $44.6M, a sequential improvement in EBITDA, and a net loss of $5.2M. The company announced new partnerships with Novo Nordisk, Eli Lilly, and AT&T, and expects Q4 revenue between $46M and $49M.
Key Retail Themes:
financial performance
partnerships
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 15, 2026 3:54 AM ET
Data refreshes hourly during market hours. Next update: 4:54 AM
Data refreshes hourly during market hours. Next update: 4:54 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LFMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$320 | 48 HOLD |
|
WAY
Waystar Holding Corp. CoâĻ |
STRONG BUY
23 analysts |
$35 | 37 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
18 analysts |
$83 | 42 HOLD |
|
HNGE
Hinge Health, Inc. |
STRONG BUY
17 analysts |
$135 | 49 HOLD |
|
HQY
HealthEquity Inc |
STRONG BUY
15 analysts |
$121 | 39 SELL |
Advanced LFMD Option Strategies
Professional options setups generated by AI based on today's LFMD price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive LFMD Research Pages
